1. Home
  2. GDC vs SLS Comparison

GDC vs SLS Comparison

Compare GDC & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

HOLD

Current Price

$5.23

Market Cap

215.5M

Sector

Industrials

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$4.00

Market Cap

208.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDC
SLS
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
215.5M
208.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GDC
SLS
Price
$5.23
$4.00
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
73.7K
14.3M
Earning Date
11-03-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$0.85
52 Week High
$9.92
$5.18

Technical Indicators

Market Signals
Indicator
GDC
SLS
Relative Strength Index (RSI) 61.23 60.95
Support Level $4.27 $3.23
Resistance Level $4.87 $4.42
Average True Range (ATR) 0.49 0.63
MACD 0.06 -0.04
Stochastic Oscillator 81.82 54.73

Price Performance

Historical Comparison
GDC
SLS

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: